Insider Selling: John Martin Stephens Sells 1,633 Shares of M.D.C. Holdings Stock (MDC)
M.D.C. Holdings (NYSE:MDC) CFO John Martin Stephens unloaded 1,633 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $28.56, for a total value of $46,638.48. Following the completion of the transaction, the chief financial officer now directly owns 13,150 shares of the company’s stock, valued at approximately $375,564. The transaction was disclosed in a document filed with the SEC, which is available at this link.
M.D.C. Holdings (NYSE:MDC) traded up 1.61% on Friday, hitting $28.97. The stock had a trading volume of 582,263 shares. M.D.C. Holdings has a 52-week low of $27.00 and a 52-week high of $41.14. The stock has a 50-day moving average of $30.46 and a 200-day moving average of $29.74. The company has a market cap of $1.413 billion and a P/E ratio of 4.50.
M.D.C. Holdings (NYSE:MDC) last announced its earnings results on Tuesday, February 4th. The company reported $0.62 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.59 by $0.03. The company had revenue of $461.60 million for the quarter, compared to the consensus estimate of $434.20 million. During the same quarter last year, the company posted $0.59 earnings per share. M.D.C. Holdings’s revenue was up 18.1% compared to the same quarter last year. On average, analysts predict that M.D.C. Holdings will post $1.80 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, February 26th. Shareholders of record on Wednesday, February 12th will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 3.45%. The ex-dividend date is Monday, February 10th.
A number of analysts have recently weighed in on MDC shares. Analysts at Ned Davis Research upgraded shares of M.D.C. Holdings from a “sell” rating to a “neutral” rating in a research note on Monday. Separately, analysts at Credit Suisse downgraded shares of M.D.C. Holdings from an “outperform” rating to a “neutral” rating in a research note on Monday. They now have a $30.00 price target on the stock, down previously from $36.00. Finally, analysts at TheStreet upgraded shares of M.D.C. Holdings from a “hold” rating to a “buy” rating in a research note on Friday, February 7th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the company’s stock. M.D.C. Holdings currently has an average rating of “Hold” and a consensus target price of $34.23.
M.D.C. Holdings, Inc (NYSE:MDC), incorporated on May 17, 1985, operates in the two business segments: homebuilding and financial services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.